KDR Gene

Overview

flowchart TD
    KDR["KDR"] -->|"therapeutic target"| Inflammation["Inflammation"]
    KDR["KDR"] -->|"therapeutic target"| Ms["Ms"]
    KDR["KDR"] -->|"biomarker for"| Fibrosis["Fibrosis"]
    KDR["KDR"] -->|"biomarker for"| Diabetes["Diabetes"]
    KDR["KDR"] -->|"biomarker for"| Als["Als"]
    KDR["KDR"] -->|"biomarker for"| Ms["Ms"]
    KDR["KDR"] -->|"therapeutic target"| Ulcerative_Colitis["Ulcerative Colitis"]
    KDR["KDR"] -->|"inhibits"| MMP9["MMP9"]
    KDR["KDR"] -->|"inhibits"| ICAM1["ICAM1"]
    KDR["KDR"] -->|"inhibits"| SPP1["SPP1"]
    KDR["KDR"] -->|"inhibits"| MMP2["MMP2"]
    KDR["KDR"] -->|"inhibits"| NOS2["NOS2"]
    KDR["KDR"] -->|"biomarker for"| FGF9["FGF9"]
    KDR["KDR"] -->|"biomarker for"| HSPG2["HSPG2"]
    style KDR fill:#4fc3f7,stroke:#333,color:#000

KDR (Kinase Insert Domain Receptor), also known as Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), is a receptor tyrosine kinase that serves as the primary signaling receptor for VEGF-mediated angiogenesis and vascular development. The KDR protein is a member of the VEGFR family and plays critical roles in endothelial cell proliferation, migration, survival, and vascular permeability. In the nervous system, KDR regulates neurovascular coupling, maintains blood-brain barrier (BBB) integrity, and provides neurotrophic support to neurons

The neurovascular unit, comprising endothelial cells, pericytes, astrocytes, and neurons, is essential for proper brain function. KDR/VEGFR2 is a key component of this unit, mediating communication between neural activity and vascular responses. Dysregulation of KDR signaling has been implicated in the pathogenesis of Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and other neurological disorders

Gene and Protein Structure

Gene Organization

The human KDR gene is located on chromosome 4q12 and spans approximately 44 kilobases. The gene consists of 30 exons that encode a protein of 1,356 amino acids with a molecular weight of approximately 200-230 kDa (the receptor exists as a heterodimer). The gene is conserved across vertebrates, with orthologs in mouse, rat, and other species.

Protein Domains

The KDR/VEGFR2 protein contains several functional domains:

1. Extracellular domain: Contains 7 immunoglobulin-like (Ig-like) domains involved in VEGF binding and receptor dimerization

2. Transmembrane domain: Single pass transmembrane helix

3. Juxtamembrane domain: Contains regulatory sequences including the kinase insert

4. Tyrosine kinase domain: Catalytic domain with kinase activity (~70% sequence homology with FLT1/VEGFR1)

5. C-terminal tail: Contains phosphorylation sites for signaling molecule recruitment

Structural Features

KDR functions as a homodimer upon VEGF binding:

• VEGF-A binds to the Ig-like domains 2 and 3 of the extracellular domain

• Receptor dimerization leads to autophosphorylation of tyrosine residues

• Phosphorylation activates downstream signaling pathways

Biological Functions

Vascular Function

KDR/VEGFR2 is the major VEGF signaling receptor for vascular processes^{1Endothelial signaling during development: VEGF and notch in vascular patterning2019 · Developmental Biology · DOI 10.1016/j.ydbio.2019.04.012Open reference}:

Angiogenesis:

• Primary driver of new blood vessel formation from pre-existing vessels

• Mediates endothelial cell sprouting and migration

• Essential for developmental and regenerative angiogenesis

Endothelial cell activation:

• Strong mitogenic signaling promoting endothelial proliferation

• Chemotactic signaling for endothelial cell migration

• Promotes endothelial cell survival through anti-apoptotic pathways

Vascular permeability:

• Increases vessel permeability through VE-cadherin internalization

• Mediates endothelial fenestrations

• Regulates plasma protein extravasation

Neurovascular Function

KDR plays crucial roles in the neurovascular unit^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}:

Neurovascular coupling:

• Links neural activity to blood flow regulation

• Mediates vasodilation in response to neuronal activity

• Ensures adequate blood supply matching metabolic demand

Blood-brain barrier:

• Maintains BBB integrity through tight junction regulation^{3The blood-brain barrier: structure, function, and therapeutic targeting2020 · Neurobiology of Disease · DOI 10.1016/j.nbd.2019.104721Open reference}

• Supports pericyte function and coverage

• Regulates transport across the BBB

Cerebral angiogenesis:

• Supports brain vascularization during development

• Maintains vascular homeostasis in the adult brain

• Responds to ischemic injury with angiogenic repair

Signaling Mechanisms

KDR activates multiple major signaling pathways:

Expression in the Nervous System

Cellular Distribution

KDR exhibits specific expression patterns in the nervous system:

• Endothelial cells: Primary expression site in cerebral vasculature

• Neurons: Some neuronal populations express KDR

• Neural progenitor cells: During development and in adult neurogenesis zones

• Pericytes: Supporting role in neurovascular unit

• Astrocytes: End-feet expression around blood vessels

• Some tumor cells: Cancer expression, particularly glioblastoma

Brain Region Expression

KDR is expressed throughout the brain with notable levels in:

• Hippocampus — particularly in the dentate gyrus

• Cerebral cortex — throughout all layers

• Cerebellum — Purkinje cell layer and granule cell layer

• Substantia nigra — dopaminergic neuron region

• Striatum

Regulation of Expression

KDR expression is regulated by:

• Hypoxia: HIF-1α-mediated upregulation

• VEGF: Ligand-induced receptor expression

• Shear stress: Mechanical forces from blood flow

• Growth factors: EGF, FGF

• Inflammatory cytokines: TNF-α, IL-1β

Role in Neurodegenerative Diseases

Alzheimer’s Disease

KDR is significantly implicated in AD pathophysiology^{4VEGF and neurodegeneration: the dual role of vascular endothelial growth factor in Alzheimer's disease2018 · Brain Research Bulletin · DOI 10.1016/j.brainresbull.2018.07.015Open reference}:

Neurovascular dysfunction:

• Altered KDR signaling in AD brain contributes to neurovascular dysfunction^{5Endothelial alterations in Alzheimer's disease brain2019 · Acta Neuropathologica · DOI 10.1007/s00401-019-02035-7Open reference}

• Reduced cerebral blood flow due to impaired angiogenesis

• Endothelial dysfunction affecting amyloid clearance

Blood-brain barrier breakdown:

• KDR dysregulation contributes to BBB breakdown in AD^{6VEGF-mediated blood-brain barrier dysfunction in neurodegenerative diseases2020 · Journal of Neuroinflammation · DOI 10.1186/s12974-020-01967-5Open reference}

• Increased vascular permeability allows peripheral proteins into brain

• Impaired clearance of Aβ through the BBB

Angiogenesis impairment:

• Reduced VEGF-KDR signaling limits compensatory angiogenesis

• Neurovascular unit dysfunction precedes cognitive decline

• Therapeutic potential of enhancing KDR signaling

Amyloid and tau interaction:

• Aβ can directly affect endothelial KDR signaling

• Tau pathology correlates with vascular dysfunction

• Dual targeting of vascular and neuronal pathology

Parkinson’s Disease

In PD, KDR plays important roles^{7VEGF receptor 2 signaling in Parkinson's disease: neuroprotection and angiogenesis2019 · Redox Biology · DOI 10.1016/j.redox.2019.101145Open reference}:

Substantia nigra vasculature:

• KDR in substantia nigra microvasculature is affected in PD

• Reduced angiogenesis in PD substantia nigra

• Contributes to dopaminergic neuron vulnerability

Neurovascular coupling defects:

• Impaired neurovascular coupling in PD

• Reduced cerebral blood flow

• Contributes to motor and cognitive symptoms

Neuroprotection potential:

• VEGF-KDR signaling provides neurotrophic support

• Potential for therapeutic enhancement

• Promotes dopaminergic neuron survival

Other Neurological Disorders

Stroke:

• KDR promotes post-stroke angiogenesis and blood flow recovery^{8VEGF and ischemic stroke: molecular mechanisms and therapeutic potential2019 · Journal of Molecular Neuroscience · DOI 10.1007/s12031-019-01287-4Open reference}

• Therapeutic target for ischemic stroke

• Promotes vascular remodeling and functional recovery

Retinopathy:

• KDR drives pathological angiogenesis in diabetic retinopathy

• Major therapeutic target for eye diseases

• Anti-VEGF therapies widely used clinically

Glioblastoma:

• High KDR expression in glioblastoma vasculature

• Target for anti-angiogenic therapy

• Contributes to tumor progression

Molecular Mechanisms

Signaling Pathways

KDR activates multiple downstream pathways:

PI3K/AKT pathway:

• Endothelial nitric oxide synthase (eNOS) phosphorylation

• Nitric oxide production and vasodilation^{9Endothelial nitric oxide: protector of optic nerve and brain2019 · Translational Research · DOI 10.1016/j.trsl.2019.04.006Open reference}

• Cell survival through AKT-mediated anti-apoptosis

• mTOR-mediated endothelial cell growth

MAPK/ERK pathway:

• Endothelial cell proliferation

• Cell migration and tube formation

• Integration with other growth factor signaling

PLCγ-PKC pathway:

• Calcium mobilization

• Contractile apparatus regulation

• Integration with cytoskeletal changes

Src pathway:

• VE-cadherin phosphorylation and internalization

• Increased vascular permeability

• Cytoskeletal reorganization

Interaction with Neurovascular Unit

KDR interacts with other components of the neurovascular unit:

• Pericytes: KDR signaling supports pericyte recruitment and function

• Astrocytes: VEGF from astrocytes activates endothelial KDR

• Neurons: Activity-dependent VEGF release activates neurovascular KDR

• Tight junctions: KDR regulates claudin-5, occludin expression

VEGF Isoform Specificity

KDR specifically binds VEGF-A isoforms:

• VEGF₁₂₁: Weak KDR binding, more diffuse

• VEGF₁₆₅: Optimal KDR binding,balanced activity

• VEGF₁₈₉: Strong heparin binding, local activity

Therapeutic Implications

Therapeutic Strategies

KDR is a major therapeutic target^{10Therapeutic targeting of VEGF signaling in neurodegenerative diseases2021 · Advanced Drug Delivery Reviews · DOI 10.1016/j.addr.2021.01.008Open reference}:

1. Anti-VEGF antibodies: Bevacizumab, ranibizumab

2. Tyrosine kinase inhibitors: Sorafenib, sunitinib, pazopanib

3. Receptor blocking peptides: Competitive VEGF binding

4. Gene therapy: VEGF or KDR expression modulation

Neurodegeneration-Focused Approaches

For Alzheimer’s disease:

• Enhancing KDR signaling to improve neurovascular function

• BBB-protective strategies through KDR modulation

• Combination with anti-amyloid approaches^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}0

For Parkinson’s disease:

• Neuroprotective VEGF-KDR signaling enhancement

• Supporting dopaminergic neuron survival

• Improving cerebral blood flow

Challenges and Considerations

• Dose-dependent effects: Too much or too little VEGF can be harmful

• BBB penetration: Drug delivery to CNS is challenging

• Peripheral effects: Systemic angiogenesis side effects

• Biomarker development: Patient selection for clinical trials

Key Research Findings

1. KDR mediates neurovascular coupling and BBB function^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}1

2. VEGF-KDR signaling maintains blood-brain barrier integrity^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}2

3. Neurovascular dysfunction is an early feature of AD^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}3

4. KDR signaling provides neuroprotection in PD models^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}4

5. VEGF and KDR in neurogenesis and repair^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}5

6. KDR polymorphisms associated with AD risk^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}6

7. Targeting VEGF-KDR for therapeutic intervention^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}7

8. Endothelial alterations in AD brain^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}8

9. VEGF-mediated BBB dysfunction in neurodegenerative diseases^{2VEGF signaling in neurovascular development and function in the central nervous system2020 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-020-05523-6Open reference}9

10. Neurovascular unit interactions in neurodegeneration^{3The blood-brain barrier: structure, function, and therapeutic targeting2020 · Neurobiology of Disease · DOI 10.1016/j.nbd.2019.104721Open reference}0

Cross-References

• VEGFA Gene - Primary VEGF ligand

• FLT1 Gene - VEGF receptor 1

• NRP1 Gene - Neuropilin co-receptor

• Neurovascular Coupling Mechanisms

• Blood-Brain Barrier Mechanisms

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• NCBI Gene: KDR

• UniProt: VEGFR2 (P35968)

• OMIM: 191306

• Ensembl: ENSG00000128052

• GeneCards: KDR

• IUPHAR: VEGFR2

• PubMed: KDR neurodegeneration